DaVita Inc.

DVA Healthcare Medical Care Facilities

DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024.

Revenue
+4.62%
EPS
+67.0%
Free cash flow
−45.8%
Total debt
+5.07%

Quarter to September 2026, against a year earlier

190.21 4.61 −2.37%
Market cap
$12.3B
P/E
14.0×
Fwd P/E
13.0×
Dividend yield
—
F-score
6/9
Altman Z
1.49
Beneish M
−2.59
Dividend safety
n/a

DaVita Inc. (DVA) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, DaVita Inc. (DVA) trades at a EV/Sales of 1.6×. Over the past ten years it has ranged from 1.2× (October 2023) to 2.8× (December 2017); the current reading is higher than 37% of that period. That is above the Medical Care Facilities industry median of 1.4× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.3× (19.80%)
FY2024 1.7× 14.12%
FY2023 1.5× 8.95%
FY2022 1.3× (23.76%)
FY2021 1.7× (6.69%)
FY2020 1.9× 16.02%
FY2019 1.6× (0.35%)
FY2018 1.6× (21.59%)
FY2017 2.1× 4.10%
FY2016 2.0× (9.93%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 1.5× (13.72%)
Jun 2026 1.7× 18.86%
Mar 2026 1.5× 10.57%
Dec 2025 1.3× (7.14%)
43 more quarters

Against its own ten years

Low 1.2× High 2.8×
Ten-year median 1.7×
Current reading's percentile 40

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on DVA